Fattorusso Caterina, Campiani Giuseppe, Kukreja Gagan, Persico Marco, Butini Stefania, Romano Maria Pia, Altarelli Maria, Ros Sindu, Brindisi Margherita, Savini Luisa, Novellino Ettore, Nacci Vito, Fattorusso Ernesto, Parapini Silvia, Basilico Nicoletta, Taramelli Donatella, Yardley Vanessa, Croft Simon, Borriello Marianna, Gemma Sandra
J Med Chem. 2008 Mar 13;51(5):1333-43. doi: 10.1021/jm7012375. Epub 2008 Feb 16.
Malaria is a major health problem in poverty-stricken regions where new antiparasitic drugs are urgently required at an affordable price. We report herein the design, synthesis, and biological investigation of novel antimalarial agents with low potential to develop resistance and structurally based on a highly conjugated scaffold. Starting from a new hit, the designed modifications were performed hypothesizing a specific interaction with free heme and generation of radical intermediates. This approach provided antimalarials with improved potency against chloroquine-resistant plasmodia over known drugs. A number of structure-activity relationship (SAR) trends were identified and among the analogues synthesized, the pyrrolidinylmethylarylidene and the imidazole derivatives 5r, 5t, and 8b were found as the most potent antimalarial agents of the new series. The mechanism of action of the novel compounds was investigated and their in vivo activity was assessed.
疟疾是贫困地区的一个主要健康问题,在这些地区迫切需要以可承受的价格获得新的抗寄生虫药物。我们在此报告基于高度共轭支架设计、合成并进行生物学研究的新型抗疟药,这些药物产生耐药性的可能性较低。从一个新的活性化合物出发,进行设计修饰,假设其与游离血红素发生特定相互作用并产生自由基中间体。这种方法提供了对耐氯喹疟原虫效力优于已知药物的抗疟药。确定了许多构效关系(SAR)趋势,在合成的类似物中,吡咯烷基甲基亚芳基和咪唑衍生物5r、5t和8b被发现是新系列中最有效的抗疟药。研究了新型化合物的作用机制并评估了它们的体内活性。